Most people assume the big-name brands are the safe bet. They are not always the smart bet. After spending several months signing up for, getting assessed by, and actually receiving medication from seven different online GLP-1 services, I found that price and pharmacy transparency vary wildly, and the loudest advertisers are not always the best option.
Here is what I found, ranked from top pick to “fine, but not my first choice.”
1. HealthRX
Verdict: Best overall for cash-pay patients who want fast access and a named pharmacy.
The price is the first thing that stops you. Compounded semaglutide starts at $99 per month and compounded tirzepatide at $149 per month, with free overnight shipping to all 50 states. That combination is hard to find anywhere else at this price tier.
What actually earned HealthRX the top spot for me was the pharmacy disclosure. The medication comes from Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-tracked batches. It holds LegitScript certification (cert 50087439). Most telehealth services either name no pharmacy at all or bury that information. Physician review happens within roughly 24 hours of your online assessment.
Compounded medications are not FDA-approved. That is true of every compounded GLP-1 option on this list and worth keeping in mind.
2. Mochi Health
Verdict: Best monitoring for people who want obesity-medicine specialists, not just a script.
Mochi puts board-certified obesity-medicine clinicians on your case, not general practitioners. Monthly costs typically land near $99 for compounded semaglutide and $199 for tirzepatide. The ongoing check-ins are more structured than most platforms I tested. If you want a provider who will actually adjust your dosing based on side effects rather than auto-refill, Mochi is worth the attention.
3. FormBlends
Verdict: Best pick if published lab testing matters to you, or if you want GLP-1s alongside a wider peptide catalog.
FormBlends is worth a close look for a specific kind of buyer. It publishes per-product purity testing results, including HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin and sterility data, with named numbers attached. That level of transparency is uncommon in this category.
Medication comes from an FDA-registered 503A compounding pharmacy, and the service ships to 47 states. Pricing is higher than HealthRX, semaglutide around $299 per vial and tirzepatide around $349, so the value proposition is about verification and range rather than cost.
The other differentiator is catalog breadth. FormBlends carries recovery, longevity, and cognitive peptides alongside its GLP-1 offerings under the same clinician model. If you want one provider for more than just weight loss, that matters. For pure price-per-month value, HealthRX wins. For someone who wants to see the COA before injecting anything, FormBlends is the better fit.
4. Hims & Hers
Verdict: Recognizable brand, now focused on branded medications after exiting compounded GLP-1s in early 2026.
After the Novo Nordisk settlement in March 2026, Hims & Hers shifted away from compounded semaglutide. Injectable Wegovy through the platform runs around $299 per month, oral semaglutide around $249, and Zepbound around $399. With insurance plus a manufacturer savings card, costs can drop to near zero for qualifying patients. Good option if you have insurance coverage or want branded medication. Less compelling for strict cash-pay situations.
5. Ro Body
Verdict: Solid infrastructure for insurance navigation, weaker on cash pricing.
Ro’s first month runs around $39, then roughly $74 to $149 per month for the platform, with medications billed separately. The prior-authorization team is a real asset. If your insurer might cover branded GLP-1s and you do not want to handle the paperwork yourself, Ro is genuinely useful there. The total monthly cost once you add meds can climb fast, though.
6. Henry Meds
Verdict: Fast shipping, simple model, lighter on clinical oversight.
Henry Meds ships compounded medication within 24 to 72 hours of approval, which is among the faster turnarounds I saw. The first month runs somewhere between $179 and $249 depending on the medication selected. The tradeoff is monitoring. Check-ins are lighter compared to Mochi or Form Health. Fine for people who are self-directed and have prior GLP-1 experience. Less ideal if you want frequent clinical touchpoints.
7. PlushCare
Verdict: Best for same-day visits and insurance-first patients.
PlushCare charges around $19.99 per month for membership and focuses on branded medications through insurance. Same-day appointments are genuinely available, which almost no other service on this list can claim. If your goal is getting a branded Wegovy or Ozempic prescription covered through your plan as quickly as possible, PlushCare is the most direct path. For uninsured or cash-pay patients, the branded med pricing without coverage makes it less competitive.
Quick Comparison
| Provider | Starting Price | Compounded? | Ships All 50 States |
| HealthRX | $99/mo (sema) | Yes | Yes |
| Mochi Health | $99/mo (sema) | Yes | Yes |
| FormBlends | ~$299/vial (sema) | Yes | 47 states |
| Hims & Hers | ~$249-299/mo | No (post-2026) | Yes |
| Ro Body | ~$39 first mo + meds | No | Yes |
| Henry Meds | ~$179 first mo | Yes | Yes |
| PlushCare | ~$19.99/mo + meds | No | Yes |
Prices reflect publicly available information as of mid-2026 and can change. Compounded GLP-1s are not FDA-approved finished drug products. Talk to a licensed clinician before starting any weight-loss medication.
Common Questions
Does it matter which compounding pharmacy a telehealth service uses?
Yes, and more than most people realize. A 503A pharmacy like the one HealthRX names (Manifest Pharmacy, LegitScript cert 50087439) operates under USP-797 sterility standards with lot-tracked batches. Services that disclose nothing about their pharmacy source give you no way to verify those same controls are in place before you inject anything.
After the Hims & Hers settlement in March 2026, can any telehealth platform still legally prescribe compounded semaglutide?
Compounded semaglutide from 503A pharmacies remains available through platforms like HealthRX, Mochi Health, Henry Meds, and FormBlends as of mid-2026. The Novo Nordisk settlement specifically affected Hims & Hers. The broader legal picture is still shifting, so checking a provider’s current status before signing up is worth the two minutes.
Is the $99 per month price from HealthRX actually all-in, or are there fees on top?
Based on publicly available pricing, the $99 per month covers compounded semaglutide with free overnight shipping included. Physician assessment fees and any dose-escalation costs are worth confirming directly before checkout, since telehealth platforms occasionally bill those separately from the base medication price.
How do Mochi Health and PlushCare differ for someone whose insurance might cover a branded GLP-1?
Mochi focuses on clinical depth, pairing you with obesity-medicine specialists who adjust dosing over time, but it leans toward compounded options. PlushCare targets insurance-first patients specifically, offers same-day appointments, and pushes branded Wegovy or Ozempic through your plan. If prior-authorization support matters, Ro Body is also worth comparing directly against PlushCare.
What does FormBlends’ published lab testing actually include, and why don’t other services do the same?
FormBlends posts HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin and sterility results with specific numbers attached. Most services skip this because it adds cost and creates accountability. For a patient who wants to verify potency and identity before injecting a compounded peptide, that documentation is the core reason to pay FormBlends’ higher per-vial price.
Sources
- FDA warning letters to telehealth and compounding firms (early 2026), FDA.gov
- Novo Nordisk settlement with telehealth compounders, March 9, 2026, Reuters and STAT News reporting
- SURMOUNT-1 tirzepatide trial (72-week, ~21% body weight loss), *New England Journal of Medicine*, 2022
- STEP 1 semaglutide trial (68-week, ~15% body weight loss), *New England Journal of Medicine*, 2021
- LegitScript pharmacy certification database, LegitScript.com
- Individual brand pricing pages reviewed directly, May-June 2026
